|
|
Legal status
Patent expired
| (51) | INT.CL.: (2006.01) |
A61K 9/08 A61K 9/14 A61K 9/19 A61K 38/18 A61K 38/22 A61K 47/00 A61P 25/00 |
| (11) | Number of the document | 4051 |
| (13) | Kind of document | B |
| (21) | Application number | 96-011 |
| (22) | Date of filing the application | 1996-02-19 |
| (41) | Date of publication of the application | 1996-07-25 |
| (45) | Date of publication of patent | 1996-10-25 |
| (86) | Number | PCT/US94/09245 |
| Date | 1994-08-16 |
| (87) | Number | WO 95/05845 |
| Date | 1995-03-02 |
| (30) | Number | Date | Country code |
| 109798 | 1993-08-20 | US |
| (71) |
SYNTEX (U.S.A.) INC.,
3401 Hillview Avenue, Palo Alto, CA 94304,
US
|
| (72) |
Victoria M. KNEPP, US
Deborah M. LIDGATE, US Richard MASKIEWICZ, US Leo GU, US |
| (73) |
SYNTEX (U.S.A.) INC.,
3401 Hillview Avenue, Palo Alto, CA 94304,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | PHARMACEUTICAL FORMULATIONS OF NERVE GROWTH FACTOR |
| Payment date | Validity (years) | Amount | |
| 2013-07-30 | 20 | 1200.00 LTL |
| Patent expired | ||
| Invalidation date | 2014-08-16 |